Abiopharma

🔍 LOTT RONALD M. (Director)

Company: SURO CAPITAL CORP. (SSSS)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 3,536 shares of Common Stock (Direct)
  Date: 2026-06-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,536.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-10 | Code: H | nature_of_ownership: By Family Trust | shares_owned_after: 18,481.00 | Footnotes: F2

Footnotes:

• F1: Relates to restricted shares granted under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan, which are scheduled to vest in full on the earlier of (i) the first anniversary of the award date (with such first anniversary being June 10, 2027) and (ii) the date of SuRo Capital Corp.'s annual meeting of stockholders that is closest to the first anniversary of the award date. In connection with the approval of the Company's externalization by its stockholders, the Board of Directors of the Company may, in its sole discretion, accelerate the vesting of these shares.
• F2: These shares are held of record by the Ronald M. Lott Family Trust dtd 3/9/1992 (the "Trust"), of which Mr. Lott is a trustee and beneficiary, and may be deemed to be beneficially owned by Mr. Lott. Mr. Lott disclaims beneficial ownership of the shares held by the Trust except to the extent of his pecuniary interest therein.